Search PubMed⌕ Search

PubMed · 10287638

Facilitating medication incident analysis through computerization.

Abstract

A computer program to facilitate medication incident analysis is described. This program was developed to provide the hospital's Medication Quality Assurance Committee with more meaningful data on medication incidents in an easily accessible database as well as enhanced data storage. The menu-driven program was developed on an Olivetti M-24 SP microcomputer using Lotus 1-2-3 and Harvard Business Graphics software. The structured format of the database contains specific information from each individual medication incident report. On a monthly basis, macro commands are used to extract criteria-based data from the database and present this information in a tabular format. In addition, annual data tables are complied to provide year-to-date data summaries. The database and tables are copied and stored on a computer diskette each month. This computer program has provided the Medication Quality Assurance Committee with an improved system for medication incident data analysis. The major benefit of this computer program over the previous manual system is the more timely identification of medication-related practices requiring closer monitoring and/or revision to improve patient care.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D G Pankoski, B A Dinel. 1988. Facilitating medication incident analysis through computerization.. https://pubmed.ncbi.nlm.nih.gov/10287638/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Estimating the percentage of Papanicolaou smears that can be reproducibly identified: modeling Papanicolaou smear interpretation based on multiple blinded rescreenings.

BACKGROUND: Multiple blinded rescreenings of Papanicolaou (Pap) smears for litigation purposes is based on the assumption that a subset of Pap smears can be reproducibly identified. The size of this subset is not known. METHODS: To estimate the size of the subset of Pap smears that can be reproducibly identified, a model was constructed based on the results of repeated blinded screenings in the AutoPap Primary Screening System Trial. Additional analysis came from data in the literature. RESULTS: Routine and AutoPap-assisted screening both have a detection rate for all detected abnormal cases of < 50%. Models with only two subsets or types of slides each with a different detection rate correlated well with the available data. Data from multiple rapid reviews strongly supported the existence of additional definable subsets. Although the percentage of cases with an expected detection rate of 100% in a three-subset model might have been as high as 30% of the abnormal cases detected in a single review, all estimates that included a second subset of slides with at least a 50% detection rate limited the percentage of slides in the 100% sensitive subset of slides to < 2% of all abnormal slides and < 6% of all abnormal slides detected by a single screening. CONCLUSIONS: Repeated screenings of Pap smears allowed more accurate models of the sensitivity of Pap-smear screening and the overall incidence of abnormal cases. The data strongly supported the existence of multiple subsets of Pap smears, which can be defined by repeated blinded rescreenings. The percentage of slides that can be reproducibly identified was small.

Data Interpretation, Statistical↗